to:!207/899/0968! !!!!!!!!!!!!!!phone:!207/899/0939 ... · pdf file ·...
TRANSCRIPT
![Page 1: TO:!207/899/0968! !!!!!!!!!!!!!!PHONE:!207/899/0939 ... · PDF file · 2017-04-21Title: Microsoft Word - Rheumatology IV Enrollment Form ABD Created Date: 20161003152234Z](https://reader031.vdocuments.net/reader031/viewer/2022020214/5ab3ed217f8b9adc638b9b90/html5/thumbnails/1.jpg)
PLEASE FAX TO: 207-‐899-‐0968 PHONE: 207-‐899-‐0939
RHEUMATOLOGY IV ENROLLMENT FORM PATIENT INFORMATION
Patient Name: Date of Birth: ! Male ! Female Address: Phone: Alternate Phone: Height: Weight: Insurance Information: ! Attached Allergies:
DIAGNOSIS Date of diagnosis: _____ □ Psoriatic arthritis (L40.52) □ Ankylosing spondylitis (M45.9) □ Rheumatoid arthritis (M05) □ Osteoarthritis (M19.90) □ Polyarticular juvenile RA (M08.00) □ Osteoporosis (M81.0) □ Uveitis: NI Intermediate (H_____________) □ Posterior (H_____________) □ Panuveitis (H____________) □ Other: (ICD-‐10 )
PPD skin test performed? □ yes □ no Date: ____________ Current therapy: ______________________________________
Stop before starting new therapy? □ yes □ no Withhold for how long before starting: _____________
Previously failed DMARDs: ______________________________ Previously failed biologics: ______________________________
CLINICAL INFORMATION Current therapy: ______________________________________ Previously failed DMARDs: ____________________________________ Stop before starting new therapy? ! Yes ! No Previously failed biologics: ____________________________________ Withhold for how long before starting: _____________ DRUG DIRECTIONS QTY REFILLS □ ACTEMRA 20 mg/mL (vial sizes: 4 mL, 10 mL, 20 mL) “maximum dose per infusion: 800 mg”
□ Initial dose: 4 mg/kg __________mg IV every 4 weeks □ 162 mg SQ weekly (>100 kg) □ Maintenance: 8 mg/kg _________mg IV every 4 weeks
□ ORENCIA-‐IV 250 mg vial □ Less than 60 kg, dose: 500 mg □ 60-‐100 kg, dose: 750 mg □ Greater than 100 kg, dose: 1000 mg
□ New start: IV infusion at week 0, week 2, week 4, then □ Maintenance dose: IV infusion every 4 weeks
□ REMICADE 100 mg vial □ New start: _________mg/kg _________ mg IV on week 0, week 2 and week 6, then □ Maintenance dose: _________mg/kg _________ mg IV every ____ weeks
□ RITUXAN 1000 mg IV infusion As directed on: □ Day 1 & □ Day 15 (will dispense available vial size) □ Other:____________________
□ RECLAST (5 mg/100mL vial) 5 mg IV every year
□ SIMPONI ARIA (50 mg/4 mL single-‐use vial) □ Initial dose: 2 mg/kg __________mg IV at weeks 0 and 4 □ Maintenance: 2 mg/kg _________mg IV every 8 weeks
! OTHER:
! Patient is ready to start treatment, contact patient for delivery ! Ship all orders to office
! Ship first order to office, subsequent orders to patient
SIGNATURE DATE:
PHYSICIAN NAME: DEA #: NPI #: STATE LICENSE #:
PRACTICE NAME: ADDRESS: CITY, STATE: ZIP:
PHONE #: FAX: OFFICE CONTACT:
Your signature authorizes the pharmacy to act on your behalf to obtain prior authorization for the prescribed medications. We will also pursue available copay and financial assistance on behalf of your patients. Following prior authorization, if insurance dictates the prescription be filled at a specific pharmacy ABD will forward the prescription to that pharmacy and the office and patient will be notified
10.03.2016